Systematic elucidation of the bioactive alkaloids and potential mechanism from Sophora flavescens for the treatment of eczema via network pharmacology

被引:16
作者
Lin, Yan [1 ,2 ,3 ,4 ]
Chen, Xing-Jun [1 ,2 ,3 ,4 ]
He, Lei [1 ,2 ,3 ,4 ]
Yan, Xue-Long [1 ,2 ,3 ,4 ]
Li, Qi-Rui [1 ,2 ,3 ,4 ]
Zhang, Xu [1 ,2 ,3 ,4 ]
He, Ming-Hui [1 ,2 ,3 ,4 ]
Chang, Shuai [1 ,2 ,3 ,4 ]
Tu, Bo [1 ,2 ,3 ,4 ]
Long, Qing-De [1 ,2 ,3 ,4 ]
Zeng, Zhu [1 ,2 ,3 ,4 ]
机构
[1] Guizhou Med Univ, Engn Res Ctr Cellular Immunotherapy Guizhou Prov, Key Lab Infect Immune & Antibody Engn Guizhou Prov, Guiyang 550025, Peoples R China
[2] Guizhou Med Univ, Sch Pharmaceut Sci, Guian New Dist 550025, Guizhou, Peoples R China
[3] Guizhou Med Univ, Immune Cells & Antibody Engn Res Ctr Guizhou Prov, Key Lab Biol & Med Engn, Guiyang 550025, Peoples R China
[4] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guiyang 550025, Peoples R China
关键词
Sophora flavescens; Eczema; Alkaloids; Molecular mechanism; Network pharmacology; TRADITIONAL CHINESE MEDICINE; DERMATITIS; CELLS;
D O I
10.1016/j.jep.2022.115799
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
Ethnopharmacology relevance: Sophora flavescens is a frequently used traditional Chinese medicine (TCM) for the treatment of skin disorders, diarrhea, vaginal itching and inflammatory diseases. In particular, the root of S. flavescens combination with other herbs mainly treat eczema ailment in the clinical applications. However, a holistic network pharmacology approach to understanding the mechanism by which alkaloids in S. flavescens treat eczema has not been pursued.Aim of the study: To examine the network pharmacological potential effect of S. flavescens on eczema, we studied the alkaloids, performed protein targets prediction and investigated interacting signal pathways. Furthermore, animal experiment was carried out to evaluate its efficacy and real-time quantitative polymerase chain reactions (RT-qPCR) analysis was explored the mechanism of action.Materials and methods: The detail information on alkaloids from S. flavescens were obtained from a handful of public databases on the basis of oral bioavailability (OB >= 30%) and drug-likeness (DL >= 0.18). Then, corre-lations between compounds and protein targets were linked using the STRING database, and targets associated with eczema were gathered by the GeneCards database. Human genes were identified and subjected to Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis and Gene Ontology (GO) functional enrichment analysis. Particularly, matrine, the crucial alkaloid from S. flavescens, was estimated using a 2,4-dinitrochloro-benzene (DNCB)-induced eczema Kunming (KM) mice model, administered (50 mg/kg and 10 mg/kg) to mice for 22 days. On the last day, the activities of serum tumor necrosis factor alpha (TNF-alpha), interleukin-4 (IL-4) and histopathologic examinations were determined. For further to elucidate the mechanisms, the mRNA levels of TNF-alpha, STAT3, TP53, AKT1, IL-6, JUN and EGFR in dorsal skin tissues were also tested.Results: Network analysis collected and identified 35 alkaloids from S. flavescens. Among them, in total 10 dominating alkaloids, including matrine, oxymatrine, sophoridine, sophocarpine, oxysophocarpine, allomatrine, sophoramine, anagyrine, cytisine and N-methylcytisine. And 71 related targets were provided of alkaloids for the treatment of eczema from S. flavescens. Furthermore, matrine dose-dependently (50 or 10 mg/kg, 22 days, apply to dorsal skin) remarkable decreased the serum levels of TNF-alpha and IL-4, and significantly alleviated the skin lesions. The effects of 50 mg/kg of matrine were almost identical to those of 200 mg/kg of the positive drug dexamethasone (DXM). The further RT-qPCR analyses could reveal that matrine down-regulate TNF-alpha, STAT3 and TP53 at transcriptional level in dorsal skin tissues.Conclusion: Pharmacological network analysis can utilize to illuminate the pharmacodynamic substances and the potential molecular mechanism of S. flavescens for treating eczema. Matrine, as the crucial alkaloid from S. flavescens, could be a promising drug candidate for the treatment of eczema ailment.
引用
收藏
页数:10
相关论文
共 33 条
[11]   Lavandulyl flavanones from Sophora flavescens protect mouse hippocampal cells against glutamate-induced neurotoxicity via the induction of heme oxygenase-1 [J].
Jeong, Gil-Saeng ;
Li, Bin ;
Lee, Dong-Sung ;
Byun, Erisa ;
An, Ren-Bo ;
Pae, Hyun-Ock ;
Chung, Hun-Taeg ;
Youn, Kwon-Ha ;
Kim, Youn-Chul .
BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2008, 31 (10) :1964-1967
[12]   Gardenia Jasminoides Ameliorates Antibiotic-Associated Aggravation of DNCB-Induced Atopic Dermatitis by Restoring the Intestinal Microbiome Profile [J].
Kim, Hyo In ;
Hong, Se Hyang ;
Lee, Seo Yeon ;
Ku, Jin Mo ;
Kim, Min Jeong ;
Ko, Seong-Gyu .
NUTRIENTS, 2021, 13 (04)
[13]   Effect of Sophora flavescens Aiton extract on degranulation of mast cells and contact dermatitis induced by dinitrofluorobenzene in mice [J].
Kim, Hyungwoo ;
Lee, Mi Ran ;
Lee, Guem San ;
An, Won Gun ;
Cho, Su In .
JOURNAL OF ETHNOPHARMACOLOGY, 2012, 142 (01) :253-258
[14]   Phytochemistry and biological properties of isoprenoid flavonoids from Sophora flavescens Ait [J].
Li, Jing-jing ;
Zhang, Xu ;
Shen, Xiang-chun ;
Long, Qing-de ;
Xu, Chang-yan ;
Tan, Chuan-jiao ;
Lin, Yan .
FITOTERAPIA, 2020, 143
[15]  
Li NF, 2018, INT J CLIN EXP PATHO, V11, P5232
[16]  
Li S, 2013, CHIN J NAT MEDICINES, V11, P110, DOI [10.3724/SP.J.1009.2013.00110, 10.1016/S1875-5364(13)60037-0]
[17]   Salvation of the fallen angel: Reactivating mutant p53 [J].
Li, Yang ;
Wang, Zhuoyi ;
Chen, Yuchen ;
Petersen, Robert B. ;
Zheng, Ling ;
Huang, Kun .
BRITISH JOURNAL OF PHARMACOLOGY, 2019, 176 (07) :817-831
[18]   Genetic and Epigenetic Aspects of Atopic Dermatitis [J].
Nedoszytko, Boguslaw ;
Reszka, Edyta ;
Gutowska-Owsiak, Danuta ;
Trzeciak, Magdalena ;
Lange, Magdalena ;
Jarczak, Justyna ;
Niedoszytko, Marek ;
Jablonska, Ewa ;
Romantowski, Jan ;
Strapagiel, Dominik ;
Skokowski, Jaroslaw ;
Siekierzycka, Anna ;
Nowicki, Roman J. ;
Dobrucki, Iwona T. ;
Zaryczariska, Anna ;
Kalinowski, Leszek .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (18) :1-18
[19]   New and Emerging Systemic Treatments for Atopic Dermatitis [J].
Newsom, Megan ;
Bashyam, Arjun M. ;
Balogh, Esther A. ;
Feldman, Steven R. ;
Strowd, Lindsay C. .
DRUGS, 2020, 80 (11) :1041-1052
[20]   A systematic review and meta-analysis of risk factors associated with atopic dermatitis in Asia [J].
Ng, Yu Ting ;
Chew, Fook Tim .
WORLD ALLERGY ORGANIZATION JOURNAL, 2020, 13 (11)